The Landscape of Targeted Therapies in TNBC

Triple negative breast cancer (TNBC) constitutes the most aggressive molecular subtype among breast tumors. Despite progress on the underlying tumor biology, clinical outcomes for TNBC unfortunately remain poor. The median overall survival for patients with metastatic TNBC is approximately eighteen...

Descripción completa

Detalles Bibliográficos
Autores principales: Vagia, Elena, Mahalingam, Devalingam, Cristofanilli, Massimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226210/
https://www.ncbi.nlm.nih.gov/pubmed/32276534
http://dx.doi.org/10.3390/cancers12040916

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226210/
https://www.ncbi.nlm.nih.gov/pubmed/32276534
http://dx.doi.org/10.3390/cancers12040916

Ejemplares similares